Who are our partners?

BIOALVO seeks to collaborate with potential partners for taking our lead structures forward in our pipeline using risk sharing models approach.

We look for collaborations where our partners can take advantage of our proprietary innovative technology (GPS D2) for drug discovery and compound screening/ reprofiling.
We customize the technology platform according to partners needs building the screening applications to study a variety of targets. For examples about some of the targets identified, please see list of potential targets.

BIOALVO welcomes partners willing to have access to its unique natural extracts library (PharmaBUG) to study it for indications outside the CNS field.The overall partnering strategy is focused on leveraging the value of the discovery platform and the developments derived thereof, always aiming to address the high failure rates in drug discovery while fueling BIOALVO’S pipeline. Partnerships can happen at different stages of the drug development depending on the programmes and partners.